Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05245032 · ClinicalTrials.gov registry record
Biologically Focused Therapy of Treatment-Refractory MDS Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 33
- Enrollment target
NCT05245032: Completed study, sponsored by Stanford University.
NCT05245032 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05245032 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
This non interventional study examines the feasibility of using patient specific therapeutic screening method, ex vivo to enhance current treatment recommendations in a clinically feasible time frame of 30 days.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2022-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05245032
The ClinicalTrials.gov registry entry for NCT05245032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05245032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05245032 about?
NCT05245032 is a clinical study titled "Biologically Focused Therapy of Treatment-Refractory MDS Patients". This non interventional study examines the feasibility of using patient specific therapeutic screening method, ex vivo to enhance current treatment recommendations in a clinically feasible time frame of 30 days.
What is the current status of trial NCT05245032?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2020-02-18. Estimated completion is 2022-12-01.
Who is sponsoring clinical trial NCT05245032?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.